All Companies

STLNCongressional Stock Trades

The Oncology Institute, Inc.

Medical Care Facilities

Congressional stock trades in The Oncology Institute, Inc. (STLN) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

12

Politicians Trading

1

Last Traded

Sep 23, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
No congressional trades found.

Price History

About The Oncology Institute, Inc.

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.

FAQ

1 members of Congress have disclosed 12 trades in The Oncology Institute, Inc. (STLN). Most active: Richard Blumenthal (12).

Across all disclosures, members of Congress reported 0 purchases and 12 sales of The Oncology Institute, Inc. (STLN). The most recent trade was on Sep 23, 2026.

Richard Blumenthal disclosed selling The Oncology Institute, Inc. (STLN) on Sep 23, 2026, valued at $1,001 - $15,000.

From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.